Trends in the development of new antiviral agents for the chemotherapy of infections caused by herpesviruses and retroviruses

This publication has 96 references indexed in Scilit:

• Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2′-deoxyuridine
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1994
• 5-Ethynyluracil (776C85): Protection from 5-fluorouracil-induced neurotoxicity in dogs
  Biochemical Pharmacology, 1994
• Antiviral Activity Spectrum and Target of Action of Different Classes of Nucleoside Analogues
  Nucleosides and Nucleotides, 1994
• Pharmacokinetics and antiviral activity of a novel isonucleoside, BMS-181165, against simian varicella virus infection in African green monkeys
  Antiviral Research, 1994
• 5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil.
  Proceedings of the National Academy of Sciences, 1993
• Synthesis and antiviral activity of novel isonucleoside analogs
  Journal of Medicinal Chemistry, 1993
• Antiviral Agents: Characteristic Activity Spectrum Depending on the Molecular Target With Which They Interact
  Published by Elsevier ,1993
• 5-Alkynyl Pyrimidine Nucleosides as Potent Selective Inhibitors of Varicella-Zoster Virus
  Antiviral Chemistry and Chemotherapy, 1992
• Antiviral therapy: current concepts and practices
  Clinical Microbiology Reviews, 1992
• 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication
  Journal of Medicinal Chemistry, 1991